About Us

We help clients assess chemical compound safety to develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products. At the frontline of next generation risk assessment (NGRA), we develop customized cell-based assays to determine safety, model chemical disposition in the body, and analyze and interpret genetic data. Our solutions save our clients time and money by bringing their products to market faster.

Latest News (See all)

When: Feb. 23, 11am EST Medium: Zoom Webinar Presenter: Andy Nong, PhD Title: Application of Toxicokinetics Modeling for the Prioritization of Chemical Groupings Please join us on Tuesday, Feb. 23, for… Read more »

PFAS PBPK Models: Current Status and Progress Needed To Predict Hypothalamic-Pituitary-Thyroid Axis Perturbations
Please join us on Monday, Feb. 8, for a special educational webinar presented by Dr. Jeffrey Fisher, Senior Science Fellow for the Computational Biology Division of ScitoVation.

Featured Offering

ScitoVation and BioSpyder are excited to introduce our new transcriptomics analysis package, ScitoXpress™. ScitoXpress™ provides important information about points of departure (POD) and potential modes of action (MoA) for our clients’ compounds. ScitoXpress™ characterizes chemical risk cost-efficiently and rapidly.

Because changes in gene expression precede changes in phenotype, a robust transcriptomics package like ScitoXpress™ can provide answers at lower doses compared to disease or tumor endpoints are typical used in in vivo studies. ScitoXpress™ offers the additional advantages of:

  • Providing utility in guiding additional studies, resulting in cost- and time-savings
  • Being based on a rigorous scientific approach, applied by experts
  • Having the support of U.S. EPA

 

Who We Serve

By combining modern biological and computational methods, we help our clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals and consumer products.

Blog

Using Physiologically Based Pharmacokinetic (PBPK) Modeling and In vitro to In vivo Extrapolation (IVIVE) in Risk Assessment

To kick off a new year and decade, we assessed ScitoVation’s current and prospective positioning in the risk assessment community.  As part of that process, the leadership team reviewed our… Read more »

By Mel Andersen, Ph.D., Senior Program Advisor It’s a grand time to be a toxicologist committed to using non-animal based biological and computational methods to assess the safety of chemicals and chemical products for human populations.  My toxicology career… Read more »